HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong Yin Selected Research

Lung Neoplasms (Lung Cancer)

3/2017Preliminary comparison of diffusion-weighted MRI and PET/CT in predicting histological type and malignancy of lung cancer.
2/2014DW MRI at 3.0 T versus FDG PET/CT for detection of malignant pulmonary tumors.
6/2012Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms.
1/2012Curcumin: updated molecular mechanisms and intervention targets in human lung cancer.
8/2010Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong Yin Research Topics

Disease

63Neoplasms (Cancer)
12/2023 - 09/2002
50Infections
04/2024 - 12/2002
17Schizophrenia (Dementia Praecox)
01/2023 - 01/2018
12Theileriasis
03/2022 - 09/2007
12Breast Neoplasms (Breast Cancer)
01/2020 - 06/2010
11Retinopathy of Prematurity (Retrolental Fibroplasia)
01/2022 - 03/2013
8Inflammation (Inflammations)
01/2023 - 11/2013
7Virus Diseases (Viral Diseases)
02/2023 - 06/2002
7Neoplasm Metastasis (Metastasis)
05/2022 - 01/2005
6Babesiosis (Piroplasmosis)
12/2022 - 10/2015
6Hypoxia (Hypoxemia)
01/2020 - 04/2007
6Toxoplasmosis
07/2015 - 01/2011
5Retinal Detachment (Retinal Detachments)
06/2022 - 07/2004
5Osteosarcoma (Osteogenic Sarcoma)
05/2021 - 01/2005
5Prostatic Neoplasms (Prostate Cancer)
03/2019 - 02/2005
5Lung Neoplasms (Lung Cancer)
03/2017 - 08/2010
4Brain Ischemia (Cerebral Ischemia)
02/2024 - 07/2014
4Infarction (Infarctions)
02/2024 - 07/2014
4Carcinogenesis
12/2023 - 07/2006
4Retinal Perforations
07/2023 - 03/2013
4Tick-Borne Diseases (Tick-Borne Disease)
01/2022 - 05/2002
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 11/2011
4Leukemia
03/2013 - 11/2004
3Lung Injury
01/2024 - 01/2019
3Body Weight (Weight, Body)
01/2024 - 11/2003
3Tick Bites
08/2023 - 01/2022
3Cognitive Dysfunction
01/2023 - 10/2004
3Disease Progression
01/2023 - 01/2014
3Hallucinations (Hallucination)
01/2022 - 12/2019
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2021 - 05/2019
3Autoimmune Diseases (Autoimmune Disease)
10/2020 - 02/2008
3Sarcoma (Soft Tissue Sarcoma)
01/2020 - 11/2014
3Ewing Sarcoma (Sarcoma, Ewing)
01/2020 - 11/2014
3Spinal Cord Diseases
05/2019 - 12/2017
3Cysts
10/2014 - 06/2007
3Tick Infestations
02/2014 - 01/2009
3Adenocarcinoma of Lung
06/2012 - 08/2010
3Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2012 - 04/2010
2Soft Tissue Infections
05/2024 - 02/2024
2Pulmonary Edema
01/2024 - 01/2019

Drug/Important Bio-Agent (IBA)

38Proteins (Proteins, Gene)FDA Link
03/2024 - 12/2002
12AntigensIBA
03/2024 - 01/2009
12EnzymesIBA
03/2024 - 09/2007
12VaccinesIBA
01/2018 - 05/2002
11MicroRNAs (MicroRNA)IBA
03/2024 - 08/2010
11DNA (Deoxyribonucleic Acid)IBA
08/2023 - 04/2006
11Biomarkers (Surrogate Marker)IBA
01/2023 - 03/2016
8AntibodiesIBA
12/2022 - 09/2007
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2022 - 03/2013
8Peptides (Polypeptides)IBA
05/2019 - 11/2011
8ImmunosorbentsIBA
02/2017 - 09/2007
718S Ribosomal RNAIBA
01/2021 - 05/2012
6Transcription Factors (Transcription Factor)IBA
09/2022 - 04/2006
6Antipsychotic Agents (Antipsychotics)IBA
01/2022 - 01/2019
5Glucose (Dextrose)FDA LinkGeneric
02/2024 - 12/2002
5RNA (Ribonucleic Acid)IBA
09/2023 - 06/2002
5Antiviral Agents (Antivirals)IBA
02/2023 - 01/2016
5CytokinesIBA
11/2021 - 03/2013
5Messenger RNA (mRNA)IBA
01/2021 - 03/2013
5Small Interfering RNA (siRNA)IBA
04/2019 - 01/2006
5IntegrinsIBA
05/2017 - 10/2002
4InterferonsIBA
02/2023 - 07/2013
4Therapeutic UsesIBA
01/2022 - 01/2017
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 10/2015
4Ranibizumab (Lucentis)FDA Link
01/2019 - 01/2017
4CurcuminIBA
06/2012 - 08/2010
4CCAAT-Enhancer-Binding Protein-alphaIBA
06/2009 - 02/2005
3Oxygen (Dioxygen)IBA
02/2024 - 04/2005
3DexmedetomidineFDA Link
02/2024 - 01/2015
3CholesterolIBA
04/2023 - 01/2012
3Transcription Factor AP-1 (Transcription Factor AP 1)IBA
05/2022 - 05/2007
3p38 Mitogen-Activated Protein KinasesIBA
05/2022 - 01/2020
3Retinaldehyde (Retinal)IBA
01/2022 - 01/2021
3Epirubicin (Ellence)FDA LinkGeneric
01/2021 - 06/2010
3GlucosidesIBA
10/2020 - 10/2019
3Docetaxel (Taxotere)FDA Link
01/2020 - 06/2010
3Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
06/2019 - 06/2014
3Caspase 3 (Caspase-3)IBA
05/2019 - 06/2012
3Membrane Proteins (Integral Membrane Proteins)IBA
11/2016 - 09/2007
3EpitopesIBA
10/2014 - 11/2011
3Serine (L-Serine)FDA Link
02/2014 - 01/2006
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2014 - 10/2002
3Phosphotransferases (Kinase)IBA
01/2013 - 05/2007
2Glycogen Synthase (Synthase I)IBA
03/2024 - 01/2017
2Anti-Bacterial Agents (Antibiotics)IBA
01/2024 - 01/2018
2Silicone OilsIBA
01/2024 - 01/2021
2Dextran SulfateIBA
01/2024 - 09/2022
2Blood Glucose (Blood Sugar)IBA
12/2023 - 09/2010

Therapy/Procedure

33Therapeutics
03/2024 - 01/2006
9Drug Therapy (Chemotherapy)
05/2021 - 06/2010
8Lasers (Laser)
06/2022 - 04/2006
7Vitrectomy
01/2024 - 07/2004
6Immunotherapy
12/2023 - 03/2010
4Anesthesia
12/2023 - 09/2007
4Transcranial Magnetic Stimulation
01/2023 - 01/2021
3Electroacupuncture
01/2024 - 07/2014
3Intravitreal Injections
06/2022 - 01/2018
3Light Coagulation
01/2022 - 11/2015
3Surgical Portasystemic Shunt (Portosystemic Shunt)
05/2019 - 12/2017
3Radiotherapy
07/2015 - 07/2010